This study demonstrates polysaccharide fermentation improves gut microbiota diversity, indicating immune effects in macrophages.
This study systematically isolated a high-molecular-weight polysaccharide (HHEP; 9.14 × 10³ kDa) from Hericium erinaceus, consisting predominantly of glucose (59.16% ± 0.09%), galactose (26.29% ± 0.59%), and mannose (5.69% ± 0.58%). Through an in vitro simulated gastrointestinal digestion and colonic fermentation model, the HHEP demonstrated remarkable resistance to digestive enzymes and gastric acid hydrolysis. However, it was effectively utilized by gut microbiota during fermentation. Detailed monitoring indicated an initial cleavage of glycosidic bonds, accompanied by a pH decrease and the formation of high-molecular-weight fragments, followed by progressive microbial degradation. Compared with inulin, HHEP selectively enriched beneficial genera, notably, Prevotella and Akkermansia. Furthermore, fermentation supernatants from early fermentation stages─when larger fragments prevailed─induced immune responses in RAW 264.7 macrophages. These results demonstrate the digestive stability and prebiotic potential of HHEP, highlighting its role as a gut-microbiota-targeting ingredient with structure-dependent immunomodulatory properties.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: